Camrelizumab With Famitinib for Patients With Rare Head and Neck Malignancies
Clinical trial NCT07662681 · RECRUITING
Trial details
- NCT number
- NCT07662681
- Sponsor
- Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-01
- Primary completion
- 2028-07-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.